Overview Fundamentals API Earnings EOD API Sample Code Pricing

Conduit Pharmaceuticals Inc. (CDTTW NASDAQ) stock market data APIs

$0.0295 0.01(58.8%) as of July 16, 2024
Price chart is built with Anychart

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Conduit Pharmaceuticals Inc. Financial Data Overview

Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CDTTW',
Type: 'Common Stock',
Name: 'Conduit Pharmaceuticals Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG016B2FLC2',
CIK: '1896212',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-09-25',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Conduit Pharmaceuticals Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Conduit Pharmaceuticals Inc. Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Conduit Pharmaceuticals Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?